Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

NCT06804395 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT06804395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06804395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
Lead sponsor
Hackensack Meridian Health
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2024
Completion date
October 1, 2034
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer risk